Akorn, Inc. (AKRX) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Akorn, Inc. Company Snapshot

Business Description:

Akorn, Inc. operates in the Pharmaceutical preparations sector. Akorn, Inc. manufactures and markets a range of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. In addition, the Company has marketed and distributed vaccines purchased from outside sources. The Company operates in three segments: ophthalmic; hospital drugs and injectables, and contract services. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois and Somerset, New Jersey. The Decatur, Illinois facilities operate as part of the Company, while the Somerset, New Jersey facility operates as Akorn (New Jersey), Inc., a wholly owned subsidiary of the Company. In our complete report available for purchase the company is compared to: Targacept, Inc., SciClone Pharmaceuticals, Inc. and Cytokinetics, Inc..

Akorn, Inc.

Stock Performance Chart for Akorn, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 12.09
(Figures in U.S. Dollars)

1 Week	8.7%		13 Weeks	10.8%

4 Weeks	28.8%		52 Weeks	127.3%

Akorn, Inc. Key Data:

	Ticker:	AKRX	Country:	UNITED STATES

	Exchanges:	NAS	Major Industry:	Drugs, Cosmetics & Health Care

			Sub Industry:	Ethical Drug Manufacturers

	2010 Sales	86,409,000 (Year Ending Jan 2011).	Employees:	410

	Currency:	U.S. Dollars	Market Cap:	1,145,520,464

	Fiscal Yr Ends:	December	Shares Outstanding:	94,749,418

	Share Type:	Common	Closely Held Shares:	49,498,068

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.